Results of a study examining the addition of Rituximab to conditioning chemotherapy in DLBCL patients undergoing stem cell transplants.
Home / Resource Library / Outcomes of Rituximab-BEAM Versus BEAM Conditioning Regimen in Patients With Diffuse Large B Cell Lymphoma Undergoing Autologous Transplantation